Stock Analysis on Net
Stock Analysis on Net

GlaxoSmithKline PLC (NYSE:GSK)

This company has been moved to the archive! The financial data has not been updated since February 27, 2015.

Analysis of Revenues

Microsoft Excel

Revenues as Reported

GlaxoSmithKline PLC, income statement, revenues

US$ in millions, translated from GBP £

Microsoft Excel
12 months ended: Dec 31, 2014 Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Pharmaceuticals and Vaccines 31,532 35,330 34,674 34,481 35,989
Consumer Healthcare turnover 7,323 8,596 8,310 8,072 7,711
Turnover by segment 38,855 43,926 42,984 42,553 43,700

Based on: 20-F (reporting date: 2014-12-31), 20-F (reporting date: 2013-12-31), 20-F (reporting date: 2012-12-31), 20-F (reporting date: 2011-12-31), 20-F (reporting date: 2010-12-31).

Item Description The company
Turnover by segment Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). GlaxoSmithKline PLC turnover by segment increased from 2012 to 2013 but then decreased significantly from 2013 to 2014.